K Park, I Shin, Y Kim, H Kang, SJ Oh, E Jang… - Frontiers in …, 2024 - frontiersin.org
Background Since NEK7 is critical for NLRP3 inflammasome activation, NEK7 inhibitors
could be employed as therapeutic agents against gout, a representative disease caused by …